FIELD: chemistry.
SUBSTANCE: invention relates to a compound of formula (I):
or pharmaceutically acceptable salts thereof, where: X is CH or N; R is hydrogen or -C1-6alkyl, said alkyl is optionally substituted with 1–3 groups Ra; R1 is hydrogen, -C1-6alkyl, -CN, -C2-6alkenyl, -(CH2)nOR or -(CH2)nhalogen; R2 is -C1-6alkyl, -OC1-6 alkyl, -C2-6alkenylR3, -C2-6alkynylR3, pyridine, pyrazole, piperidine, pyrimidine, imidazole, triazole, thiazole, pyrazine, quinoline, naphthyl, -NC(O)C6-10phenyl, -C (O) NC6-10 aryl, said alkyl, alkenyl, alkynyl, pyridine, pyrazole, piperidine, pyrimidine, imidazole, triazole, thiazole, pyrazine, quinoline, naphthyl, phenyl and aryl are optionally substituted with 1–3 groups Ra; or adjacent R1 together with R2 can form phenyl, pyrrole, furan, pyridine, piperidine, formed bicyclic ring, optionally substituted with 1–3 Ra groups; R3 is hydrogen, -C1-6alkyl, - (CH2)nN (R)2, phenyl, pyridyl, thiazole, which are optionally substituted with 1 group Ra; Ra is -C1-6alkyl, phenyl, pyridine, -CN, NO2, (CH2)nhalogen, (CH2)nOR, - (CH2)nN(R)2; Rb is hydrogen and -C1-6alkyl,; and n equals 0–4.
EFFECT: compounds can be used for treating Alzheimer's disease and other neurodegenerative diseases characterized by tau protein pathology.
24 cl, 2 dwg, 2 tbl, 57 ex
Title | Year | Author | Number |
---|---|---|---|
PYRROLO[2,3-C]PYRIDINES AS IMAGING AGENTS FOR NEUROFIBRILLARY TANGLES | 2015 |
|
RU2788916C2 |
BROMDOMAIN INHIBITORS | 2012 |
|
RU2671571C1 |
BROMDOMAIN INHIBITORS | 2012 |
|
RU2647592C2 |
HETEROCYCLIC COMPOUNDS USEFUL AS PDK1 INHIBITORS | 2010 |
|
RU2615130C2 |
SULFONAMIDE PERI-SUBSTITUTED BICYCLES FOR TREATMENT OF OCCLUSIVE AFFECTION OF ARTERIES | 2005 |
|
RU2403240C2 |
AZALACTAM COMPOUNDS AS HPK1 INHIBITORS | 2019 |
|
RU2801140C2 |
5-HT RECEPTOR MODULATORS AND METHODS FOR USING THEM | 2010 |
|
RU2542103C2 |
D-AMINO ACID OXIDASE INHIBITORS AND THEIR THERAPEUTIC USE | 2018 |
|
RU2795513C2 |
GLYCOLATOXIDASE INHIBITORS FOR THE TREATMENT OF DISEASES | 2018 |
|
RU2805308C2 |
N1/N2-LACTAM ACETYL-CoA-CARBOXYLASE INHIBITORS | 2011 |
|
RU2540337C2 |
Authors
Dates
2019-07-23—Published
2015-06-09—Filed